ProPhase Labs, Inc. Dividends, Common Stock
ProPhase Labs, Inc. (PRPH) reported Dividends, Common Stock of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Shareholders' Equity
us-gaap:DividendsCommonStock · last filed 2026-08-19
- ProPhase Labs, Inc. dividends, common stock for the quarter ending 2026-06-30 was $0.00.
- ProPhase Labs, Inc. dividends, common stock for the quarter ending 2026-03-31 was $0.00.
- ProPhase Labs, Inc. dividends, common stock for the quarter ending 2025-12-31 was $0.00.
- ProPhase Labs, Inc. dividends, common stock for the quarter ending 2025-09-30 was $0.00.
- ProPhase Labs, Inc. dividends, common stock for fiscal 2024 was $0.00.
- ProPhase Labs, Inc. dividends, common stock for fiscal 2023 was $0.00.
| Period end | Dividends, Common Stock 3 month | Dividends, Common Stock 6 month | Dividends, Common Stock 9 month | Dividends, Common Stock 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-08-19 | $0.00 10-Q · filed 2026-08-19 | $0.00 derived: sum of 3 quarters · filed 2026-08-19 | $0.00 derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $0.00 10-Q/A · filed 2026-07-09 | $0.00 derived: sum of 2 quarters · filed 2026-08-19 | $0.00 derived: sum of 3 quarters · filed 2026-08-19 | $0.00 derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-19 | $0.00 derived: sum of 2 quarters · filed 2026-08-19 | $0.00 derived: sum of 3 quarters · filed 2026-08-19 | $0.00 10-Q · filed 2026-08-19 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-19 | $0.00 derived: sum of 2 quarters · filed 2025-11-19 | $0.00 10-Q · filed 2025-11-19 | $0.00 derived: sum of 4 quarters · filed 2025-11-19 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 | $0.00 derived: sum of 2 quarters · filed 2025-08-13 | $0.00 derived: sum of 3 quarters · filed 2025-08-13 | $0.00 derived: sum of 4 quarters · filed 2025-11-19 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-20 | $0.00 derived: sum of 2 quarters · filed 2025-05-20 | $0.00 derived: sum of 3 quarters · filed 2025-11-19 | $0.00 derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $0.00 derived: sum of 2 quarters · filed 2025-11-19 | $0.00 derived: sum of 3 quarters · filed 2025-11-19 | $0.00 10-K · filed 2025-04-01 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-19 | $0.00 derived: sum of 2 quarters · filed 2025-11-19 | $0.00 10-Q · filed 2025-11-19 | $0.00 derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-13 | $0.00 10-Q · filed 2024-08-14 | $0.00 derived: sum of 3 quarters · filed 2025-08-13 | $0.00 derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-05-10 | $0.00 derived: sum of 3 quarters · filed 2024-11-13 | $0.00 derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 derived: sum of 3 quarters · filed 2024-11-13 | $0.00 10-K · filed 2024-03-29 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |